Back to Search
CHRISTA OLIVA, DOCTOR OF PHARMACY
DOCTOR OF PHARMACY
Pharmacist
NPI: 1114569662Individual
Specialties, Licenses & Credentials
Research & Publications (20)
A quantum mechanics/molecular mechanics study of the reaction mechanism of the hepatitis C virus NS3 protease with the NS5A/5B substrate.
PMID 17094110·Proteins·2007
8-other
Estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2), and epidermal growth factor receptor expression and benefit from lapatinib in a randomized trial of paclitaxel with lapatinib or placebo as first-line treatment in HER2-negative or unknown metastatic breast cancer.
PMID 19620495·J Clin Oncol·2009
2-rct
[Negative-pressure wound therapy versus standard wound dressing in the treatment of diabetic foot amputation. A randomised controlled trial].
PMID 19616774·Cir Esp·2009
4-observational
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.
PMID 19228746·Clin Cancer Res·2009
3-trial
CD14-Mac-1 interactions in Bacillus anthracis spore internalization by macrophages.
PMID 19666536·Proc Natl Acad Sci U S A·2009
7-preclinical
Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
PMID 19417026·Clin Cancer Res·2009
8-other
Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer: a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB).
PMID 18501066·Clin Breast Cancer·2008
4-observational
Temporal and spatial expression of Drosophila DLGS97 during neural development.
PMID 18501681·Gene Expr Patterns·2008
7-preclinical
Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB Trial).
PMID 18621618·Clin Breast Cancer·2008
3-trial
A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer.
PMID 18667394·Ann Oncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10400 E ALAMEDA AVE
DENVER, CO 80247 - Phone
- (303) 360-1124
Quick Facts
- NPI
- 1114569662
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile